All News AbbVie Inc. London S.E.

Equities

Market Closed - London S.E. Other stock markets 16:30:00 17/07/2024 BST			After market 20:46:10
173.3 ^USD	+2.93%		175.5	+1.30%

03:54pm	TD Cowen Adjusts Price Target on AbbVie to $195 From $180	MT
07-12	AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis	MT

TD Cowen Adjusts Price Target on AbbVie to $195 From $180	02:54pm	MT
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Giant Cell Arteritis	07-15	AQ
Ex-dividend day	07-14	FA
AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis	07-12	MT
AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis	07-12	DJ
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis	07-12	PR
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research and Development and Chief Scientific Officer	07-11	AQ
Morgan Stanley Adjusts Price Target on AbbVie to $196 From $191	07-11	MT
Redburn Atlantic Adjusts Price Target on AbbVie to $203 From $207	07-10	MT
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer	07-10	PR
Abbvie Announces Appointment of Roopal Thakkar as Executive Vice President, Research & Development and Chief Scientific Officer	07-10	CI
Mixed feelings	07-09
That's not so bad, is it?	07-08
Sector Update: Health Care Stocks Steady Premarket Friday	07-05	MT
AbbVie Flags Hit to Q2 Adjusted Earnings from R&D Expenses, Revises 2024 Outlook	07-05	MT
AbbVie cuts 2024 profit forecast	07-03	RE
AbbVie : Results of Operations and Financial Condition Form 8 K	07-03	PU
AbbVie to Host Second-Quarter 2024 Earnings Conference Call	07-02	PR
Merus Names New Chief Medical Officer	07-01	MT
AbbVie: new CEO takes up post	07-01	CF

No results for this search